This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Filter By
Reset all
Products
  • BENLYSTA

    (belimumab)

  • NUCALA

    (mepolizumab) Injection 100 mg/mL

  • Seretide MX-815

    Seretide MX-815

  • Avamys

    Avamys

  • General Vaccine Unbranded

    General Vaccine Unbranded

  • Seretide

    Seretide

Therapy
  • Asthma

  • Allergy

  • Vaccines

  • Respiratory

Duration
  • 30 minutes

  • 1 hour

  • 1.5 hours

  • 2 hours

DRY RUN - Asthma Night Live: Mild Asthma
18th February 2022 | 19:00
18 Feb, 2022 o 19:00 GMT+08:00
PM-PH-FPS-WCNT-220002
DRY RUN - Act against AMR: Managing UTI with the Latest Susceptibility data
15 Nov, 2023 o 15:00 GMT+05:30
PM-PH-ACA-WCNT-230002
Act against AMR: Managing UTI with the Latest Susceptibility data
28 Nov, 2023 o 19:00 GMT+08:00
Filter By
Reset all
Products
  • BENLYSTA

    (belimumab)

  • NUCALA

    (mepolizumab) Injection 100 mg/mL

  • Seretide MX-815

    Seretide MX-815

  • Avamys

    Avamys

  • General Vaccine Unbranded

    General Vaccine Unbranded

  • Seretide

    Seretide

Therapy
  • Asthma

  • Allergy

  • Vaccines

  • Respiratory

Duration
  • 30 minutes

  • 1 hour

  • 1.5 hours

  • 2 hours

DRY RUN - Asthma Night Live: Mild Asthma
18th February 2022 | 19:00
18 Feb, 2022 o 19:00 GMT+08:00
PM-PH-FPS-WCNT-220002
DRY RUN - Act against AMR: Managing UTI with the Latest Susceptibility data
15 Nov, 2023 o 15:00 GMT+05:30
PM-PH-ACA-WCNT-230002
Act against AMR: Managing UTI with the Latest Susceptibility data
28 Nov, 2023 o 19:00 GMT+08:00

PM-PH-ACA-WCNT-230003

AMR, antimicrobial resistance; UTI, urinary tract infection